Status:

UNKNOWN

Levels of Triglycerides and HDL-C in ACS Patients

Lead Sponsor:

Assiut University

Conditions:

Dyslipidemia Associated With Acute Coronary Syndrome

Eligibility:

All Genders

Brief Summary

Background Changes in high-density lipoprotein cholesterol and triglyceride levels have been linked to residual cardiovascular risk, whereas non-high density lipoprotein levels have been shown to be m...

Detailed Description

Dyslipidemia: A disorder of lipoprotein metabolism, including lipoprotein overproduction or deficiency. Dyslipidemias may be manifested by elevation of the total cholesterol, the "bad" low-density lip...

Eligibility Criteria

Inclusion

  • ACS
  • Normal LDL-C
  • Not on statin therapy

Exclusion

  • Liver disease
  • Drug abuse
  • End stage renal disease
  • Nephrotic syndrome
  • Drug abuse

Key Trial Info

Start Date :

June 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 1 2020

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT03429517

Start Date

June 1 2018

End Date

June 1 2020

Last Update

May 10 2019

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Assiut university hospital

Asyut, Egypt

2

Sohag Cardiac and Digestive System Center

Sohag, Egypt

Levels of Triglycerides and HDL-C in ACS Patients | DecenTrialz